AIMA
Empowering menstruators to manage their pain with freedom and dignity
* Data source: Crunchbase
- Founded
- 2019
- Employees*
- 2-10
- Funding to Date*
- $600,700
- Website
- www.my-aima.com
"Join us to close the gender pain gap and empower menstruators with freedom and dignity.”
90% of menstruators describe their period pain as moderate to severe.
AIMA, a female-led team, is developing clinically tested CBD-derived products for personalized period pain management. Their first OTC product, OVY™, is a vaginal suppository directing targeted-CBD to reduce pain and inflammation safely and effectively.